Fast-paced interviews with experts guiding the next wave of pharmaceutical and biotech innovation
BioMedWire Podcast featuring Annovis Bio Inc. (NYSE: ANVS) CEO Dr. Maria Maccecchini [Video Edition]
IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The BioMedWire Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels.
The BioMedWire Podcast showcases fast-paced interviews with industry experts pioneering pharmaceutical and biotech advancem...
IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The BioMedWire Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels.
The BioMedWire Podcast showcases fast-paced interviews with industry experts pioneering pharmaceutical and biotech advancem...
The BioMedWire Podcast features fast-paced interviews with experts guiding the next wave of pharmaceutical and biotech innovation. The latest episode features Amir Reichman, CEO of Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI), a biopharmaceutical company focused on developing inflammation and immunology biological products and on providing CDMO services through its Scinai Bioservices business unit.
To begin the interview, Reichman...
The BioMedWire Podcast features fast-paced interviews with experts guiding the next wave of pharmaceutical and biotech innovation. The latest episode features Amir Reichman, CEO of Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI), a biopharmaceutical company focused on developing inflammation and immunology biological products and on providing CDMO services through its Scinai Bioservices business unit.
To begin the interview, Reichman...
The latest episode features John Climaco, CEO of CNS Pharmaceuticals Inc. (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system.
To begin the interview, Climaco discussed CNS Pharmaceuticals’ business model, including the company’s recent announcement of an exclusive in-license agreement to expand its development pip...
The latest episode features John Climaco, CEO of CNS Pharmaceuticals Inc. (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system.
To begin the interview, Climaco discussed CNS Pharmaceuticals’ business model, including the company’s recent announcement of an exclusive in-license agreement to expand its development pip...
The latest episode features Rob Etherington, President and CEO of Clene Inc. (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases.
To begin the interview, Etherington discussed Clene’s mission, including its novel approach to the treatment of diseases such as amyotrophic lateral sclerosis (ALS) and multiple scle...
The latest episode features Rob Etherington, President and CEO of Clene Inc. (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases.
To begin the interview, Etherington discussed Clene’s mission, including its novel approach to the treatment of diseases such as amyotrophic lateral sclerosis (ALS) and multiple scle...
The latest BioMedWire podcast features Dr. Maria Maccecchini, Ph.D., Founder, President, and CEO of Annovis Bio Inc. (NYSE: ANVS), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD).
Broadcasting live from AAIC 2024, Dr. Maccecchini delves into the detailed findings from Annovis Bio’s recent Phase 2/3 Alzheimer’...
The latest BioMedWire podcast features Dr. Maria Maccecchini, Ph.D., Founder, President, and CEO of Annovis Bio Inc. (NYSE: ANVS), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD).
Broadcasting live from AAIC 2024, Dr. Maccecchini delves into the detailed findings from Annovis Bio’s recent Phase 2/3 Alzheimer’...
The BioMedWire Podcast features fast-paced interviews with experts guiding the next wave of pharmaceutical and biotech innovation. The latest episode features Amir Reichman, CEO of Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI), a biopharmaceutical company focused on developing inflammation and immunology biological products and on providing CDMO services through its Scinai Bioservices business unit.
To begin the interview, Reichman...
Conservative alt-coin podcast hosts Drew Taylor and Brent Bates recently welcomed guests and the audience to another episode of their wildly popular Wild West Crypto Show. The program took a somber turn to delve into current events in Afghanistan and remember service members and people who’ve given their lives for this country. The hosts split segments normally reserved for guests to discuss how global events will affect the market...
Conservative alt-coin podcast hosts Drew Taylor and Brent Bates recently welcomed guests and the audience to a lively episode of their wildly popular Wild West Crypto Show. The program delved into “another week at the speed of crypto.” “Folks, let me tell you something. If you’re not diversified, out of just cash, out of just the stock market,” Taylor said, shooting straight with some cowboy friendly and common-sense advice to dive...
CryptoCurrencyWire’s Jonathan Keim shared the latest and greatest in the world of cryptocurrencies, as well as special guest Greg Magarshak, the founder of Intercoin, and his team to discuss their project. “Intercoin was started with a vision that any community in the world — churches, yoga studios, also cities and universities — can have their own coin, their own currency,” Magarshak said, responding to Taylor’s question regarding...
CryptoCurrencyWire’s Jonathan Keim’s take on the latest trends in the world of cryptocurrencies. The Look and Learn segment further featured discussion surrounding the 24-hour globalization of crypto. “Crypto is 24/7. Its lights are on all the time,” Bates said, describing the nuances of cryptocurrency trading. “What a lot of people don’t realize is, with crypto, you’re not only your own compliance department … your own bank … your...
CryptoCurrencyWire’s Jonathan Keim then shined the spotlight on the latest and greatest in the world of cryptocurrencies. Perhaps the most authentically wild part of the show was spent on the hosts’ takes on the recent crazy ride of cryptos. Taylor described cryptos of late as “bucking like bodacious” and asked viewers whether they stayed on for the eight-second ride or ran for the fences. Bates then gave his view, spicing things u...
Crypto Currency Wire Communications Director, Jonathan Keim on The Wild West Crypto Show Episode 161 | BTC Taking in the Shorts, BUT Alt Coins are Rising
BroadcastMay 14, 2021. The latest news from around the cryptocurrency/blockchain space with Crypto Currency Wire's Communications Director, Jonathan Keim.
The Wild West Crypto Show is the brainchild of Drew Taylor. Drew created this platform as a tool to inform people about crypto...
CryptoCurrencyWire’s Jonathan Keim shared the latest and greatest happenings in the world of cryptocurrencies. Richard Heart also joined the program to discuss the HEX project. “The government just prints money out of thin air,” Heart said. “The price of everything just shoots up through the roof. We’ve got all-time highs in the stock market, all-time highs in cryptocurrencies, all-time highs in gold. . . All-time highs in everythi...
Crypto Currency Wire Communications Director, Jonathan Keim on The Wild West Crypto Show Episode 158 | Carnomaly Listed on KuCoin
Broadcast Apr 23, 2021. The latest news from around the cryptocurrency/blockchain space with Crypto Currency Wire's Communications Director, Jonathan Keim.
The Wild West Crypto Show is the brainchild of Drew Taylor. Drew created this platform as a tool to inform people about cryptocurrency so that they c...
Conservative alt-coin podcast hosts Drew Taylor and Brent Bates recently welcomed guests and the audience to a lively episode of their wildly popular Wild West Crypto Show. The program featured CryptoCurrencyWire’s Jonathan Keim, in a segment appropriately deemed as “Keim Time,” to highlight the latest and greatest happenings in the world of cryptocurrencies. Kristin Boggiano, the president of CrossTower Exchange, also joined the p...
I’m Jay Shetty host of On Purpose the worlds #1 Mental Health podcast and I’m so grateful you found us. I started this podcast 5 years ago to invite you into conversations and workshops that are designed to help make you happier, healthier and more healed. I believe that when you (yes you) feel seen, heard and understood you’re able to deal with relationship struggles, work challenges and life’s ups and downs with more ease and grace. I interview experts, celebrities, thought leaders and athletes so that we can grow our mindset, build better habits and uncover a side of them we’ve never seen before. New episodes every Monday and Friday. Your support means the world to me and I don’t take it for granted — click the follow button and leave a review to help us spread the love with On Purpose. I can’t wait for you to listen to your first or 500th episode!
Today’s Latest News In 4 Minutes. Updated Hourly.
The official podcast of comedian Joe Rogan.
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations.
If you can never get enough true crime... Congratulations, you’ve found your people.